Encision Deregisters Common Stock

Rhea-AI Summary

Encision (OTC PINK: ECIA) announced Board approval to file a Form 15 with the SEC on or about January 29, 2026, to voluntarily deregister common stock under Section 12(g). Effective about 90 days after filing, SEC reporting obligations (Forms 10-K, 10-Q, 8-K) will be suspended. The company cited its size, market capitalization, and compliance costs as reasons and expects cost savings. Encision says it will continue to publish unaudited quarterly and annual results and expects its shares to remain tradable OTC under ECIA, though continued market maintenance is not guaranteed.

Positive

• Suspension of SEC reporting expected to produce cost savings
• Company intends to continue publishing unaudited quarterly and annual results
• Board-approved voluntary Form 15 filing to reflect company size and compliance burden

Negative

• SEC reporting obligations (Forms 10-K, 10-Q, 8-K) will be suspended about 90 days after filing
• Company warns there is no guarantee that an over-the-counter trading market for ECIA will be maintained
• Loss of ongoing SEC filings may reduce transparency and investor access, potentially affecting liquidity

News Market Reaction

-45.13%

1 alert

-45.13% News Effect

On the day this news was published, ECIA declined 45.13%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Encision Inc. Announces Decision to Deregister its Common Stock

BOULDER, CO / ACCESS Newswire / January 29, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced today that its Board of Directors approved the filing of a Form 15 with the Securities and Exchange Commission ("SEC") to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934 ("the Exchange Act").

The Company intends to file the Form 15 on or about January 29, 2026. As a result of the filing of the Form 15, the Company's reporting obligations, including its obligations to file annual and quarterly reports on Forms 10-K, 10-Q and 8-K with the SEC, will be suspended. Other filing requirements will terminate upon the effective date of the Form 15, which is expected to occur 90 days after filing.

Encision's CEO Robert Fries commented, "The Company's decision to deregister was made after careful consideration of the advantages and disadvantages, and considering our size and market capitalization, and the high costs and demands on management's time of our ongoing compliance with SEC and Sarbanes-Oxley reporting requirements. We expect to recognize considerable cost savings associated with this decision."

Encision intends to continue to prepare and publish unaudited quarterly and annual financial results.

The Company also expects that the Company's common stock will continue to be traded in the over-the-counter market under the ticker symbol "ECIA". No guarantee, however, can be made that a trading market in the Company's common stock through any over-the-counter market will be maintained.

Encision designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, Colorado, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures.

Forward-looking Statements:
Discussions of some of the matters contained in this press release may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and, as such, may involve risks and uncertainties.

CONTACT: Mala Ray, Encision Inc, 303-444-2600, mray@encision.com

SOURCE: Encision, Inc.

View the original press release on ACCESS Newswire

FAQ

What does Encision's Form 15 filing mean for ECIA shareholders?

It suspends SEC reporting obligations about 90 days after filing, reducing formal public filings. According to the company, Forms 10-K, 10-Q and 8-K obligations will be suspended and other filing requirements will terminate upon the Form 15 effective date.

When will Encision's deregistration become effective for ECIA?

The Form 15 is expected to become effective approximately 90 days after filing. According to the company, the Form 15 is intended to be filed on or about January 29, 2026, with effectiveness roughly three months later.

Will ECIA shares still trade after Encision deregisters with the SEC?

The company expects ECIA shares to continue trading OTC, but there is no guarantee a market will be maintained. According to the company, OTC trading under the ticker ECIA is expected to continue but is not assured.

Why did Encision decide to deregister its common stock (ECIA)?

Management cited company size, market capitalization, and high compliance costs and demands on management time. According to the company, the Board expects deregistration to deliver considerable cost savings.

Will Encision stop publishing financial information after filing Form 15?

No; Encision intends to continue preparing and publishing unaudited quarterly and annual financial results. According to the company, it will still provide financial updates despite suspended SEC filing obligations.